Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 23 | 2026 | 2586 | 1.580 |
Why?
|
| Florida | 18 | 2026 | 478 | 0.770 |
Why?
|
| Apolipoprotein E4 | 5 | 2025 | 67 | 0.750 |
Why?
|
| Papillomavirus Vaccines | 7 | 2019 | 174 | 0.720 |
Why?
|
| Alzheimer Disease | 5 | 2025 | 1001 | 0.690 |
Why?
|
| Anti-Anxiety Agents | 2 | 2018 | 19 | 0.640 |
Why?
|
| Parents | 6 | 2019 | 370 | 0.590 |
Why?
|
| Papillomavirus Infections | 7 | 2019 | 376 | 0.570 |
Why?
|
| Vaccination | 5 | 2024 | 355 | 0.460 |
Why?
|
| Anti-HIV Agents | 3 | 2025 | 486 | 0.430 |
Why?
|
| Humans | 54 | 2026 | 43102 | 0.430 |
Why?
|
| Female | 40 | 2026 | 24698 | 0.420 |
Why?
|
| Residence Characteristics | 6 | 2022 | 363 | 0.410 |
Why?
|
| Hepatitis C | 2 | 2025 | 139 | 0.400 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 497 | 0.400 |
Why?
|
| Adult | 28 | 2026 | 13872 | 0.370 |
Why?
|
| Male | 33 | 2026 | 23409 | 0.370 |
Why?
|
| Depression | 3 | 2025 | 863 | 0.370 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2022 | 34 | 0.350 |
Why?
|
| Cognition | 2 | 2025 | 473 | 0.330 |
Why?
|
| Cross-Sectional Studies | 14 | 2025 | 3156 | 0.330 |
Why?
|
| Sex Factors | 5 | 2026 | 1028 | 0.320 |
Why?
|
| Viral Load | 5 | 2025 | 348 | 0.320 |
Why?
|
| Substance-Related Disorders | 4 | 2024 | 830 | 0.300 |
Why?
|
| Alcohol Drinking | 4 | 2022 | 609 | 0.300 |
Why?
|
| Middle Aged | 21 | 2026 | 12222 | 0.300 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 67 | 0.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2020 | 989 | 0.270 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2018 | 367 | 0.270 |
Why?
|
| Professional-Patient Relations | 2 | 2025 | 60 | 0.270 |
Why?
|
| Young Adult | 14 | 2026 | 5080 | 0.270 |
Why?
|
| Adolescent | 16 | 2022 | 6081 | 0.260 |
Why?
|
| Health Status Disparities | 2 | 2026 | 719 | 0.250 |
Why?
|
| Medication Adherence | 2 | 2025 | 182 | 0.240 |
Why?
|
| Minority Groups | 3 | 2025 | 690 | 0.220 |
Why?
|
| Pyridoxal Phosphate | 2 | 2022 | 11 | 0.220 |
Why?
|
| Vitamin B 6 | 2 | 2022 | 7 | 0.220 |
Why?
|
| Emigrants and Immigrants | 2 | 2019 | 158 | 0.220 |
Why?
|
| Smoking Cessation | 2 | 2022 | 590 | 0.220 |
Why?
|
| Employment | 3 | 2021 | 86 | 0.220 |
Why?
|
| Physician-Patient Relations | 1 | 2025 | 148 | 0.210 |
Why?
|
| United States | 11 | 2025 | 5205 | 0.210 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 138 | 0.200 |
Why?
|
| Religion | 3 | 2019 | 90 | 0.200 |
Why?
|
| Haiti | 4 | 2025 | 86 | 0.200 |
Why?
|
| Aged | 10 | 2025 | 8214 | 0.200 |
Why?
|
| Continuity of Patient Care | 2 | 2020 | 120 | 0.180 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 40 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2024 | 226 | 0.180 |
Why?
|
| Anomie | 1 | 2021 | 6 | 0.180 |
Why?
|
| Vitamin B Complex | 1 | 2021 | 5 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 67 | 0.160 |
Why?
|
| Food Supply | 1 | 2021 | 122 | 0.160 |
Why?
|
| Marketing | 1 | 2020 | 45 | 0.160 |
Why?
|
| Child | 8 | 2022 | 3443 | 0.160 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 2853 | 0.160 |
Why?
|
| India | 5 | 2019 | 108 | 0.160 |
Why?
|
| Brain | 2 | 2025 | 1472 | 0.160 |
Why?
|
| Self Efficacy | 1 | 2021 | 215 | 0.150 |
Why?
|
| Trazodone | 1 | 2018 | 3 | 0.150 |
Why?
|
| Genotype | 4 | 2025 | 800 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2021 | 549 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2025 | 587 | 0.140 |
Why?
|
| Mother-Child Relations | 2 | 2016 | 64 | 0.140 |
Why?
|
| Rural Population | 4 | 2026 | 373 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 590 | 0.140 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 42 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2018 | 39 | 0.130 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 281 | 0.130 |
Why?
|
| Poverty | 1 | 2021 | 400 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 195 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2025 | 1234 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 310 | 0.130 |
Why?
|
| Awareness | 1 | 2017 | 73 | 0.120 |
Why?
|
| Health Behavior | 1 | 2020 | 575 | 0.120 |
Why?
|
| Psychotherapy, Group | 1 | 2015 | 23 | 0.120 |
Why?
|
| Social Support | 1 | 2019 | 445 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2016 | 368 | 0.120 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 284 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2015 | 54 | 0.120 |
Why?
|
| Health Policy | 1 | 2017 | 184 | 0.110 |
Why?
|
| HIV-1 | 1 | 2021 | 755 | 0.110 |
Why?
|
| Parental Consent | 1 | 2014 | 3 | 0.110 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 486 | 0.110 |
Why?
|
| Hippocampus | 1 | 2018 | 594 | 0.110 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1063 | 0.100 |
Why?
|
| Risk-Taking | 1 | 2016 | 457 | 0.100 |
Why?
|
| Prevalence | 3 | 2022 | 1612 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2019 | 661 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 2 | 2023 | 160 | 0.090 |
Why?
|
| Urban Population | 3 | 2021 | 374 | 0.090 |
Why?
|
| Organ Size | 2 | 2025 | 170 | 0.090 |
Why?
|
| Mothers | 3 | 2022 | 215 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2016 | 638 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 734 | 0.090 |
Why?
|
| Schools | 3 | 2018 | 283 | 0.080 |
Why?
|
| Alcoholism | 1 | 2014 | 305 | 0.080 |
Why?
|
| Perception | 2 | 2022 | 215 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 863 | 0.080 |
Why?
|
| Logistic Models | 3 | 2021 | 1009 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 263 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2015 | 735 | 0.080 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2021 | 229 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1067 | 0.070 |
Why?
|
| Nuclear Family | 2 | 2018 | 13 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 760 | 0.060 |
Why?
|
| Educational Status | 2 | 2020 | 339 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 1759 | 0.060 |
Why?
|
| Students | 2 | 2025 | 626 | 0.060 |
Why?
|
| Acculturation | 2 | 2019 | 205 | 0.060 |
Why?
|
| Atrophy | 1 | 2025 | 51 | 0.060 |
Why?
|
| Food Dispensers, Automatic | 1 | 2025 | 4 | 0.060 |
Why?
|
| Cause of Death | 1 | 2026 | 186 | 0.060 |
Why?
|
| Heterozygote | 1 | 2024 | 110 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2024 | 74 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2024 | 2544 | 0.050 |
Why?
|
| Diethylstilbestrol | 1 | 2023 | 11 | 0.050 |
Why?
|
| Social Values | 1 | 2022 | 31 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2022 | 14 | 0.050 |
Why?
|
| Risk Factors | 2 | 2021 | 3994 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2022 | 35 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 19 | 0.050 |
Why?
|
| Phosphates | 1 | 2022 | 54 | 0.050 |
Why?
|
| Cultural Characteristics | 1 | 2022 | 128 | 0.050 |
Why?
|
| Income | 1 | 2022 | 160 | 0.040 |
Why?
|
| Universities | 1 | 2025 | 559 | 0.040 |
Why?
|
| Heroin | 1 | 2020 | 18 | 0.040 |
Why?
|
| Fentanyl | 1 | 2020 | 16 | 0.040 |
Why?
|
| Parenting | 1 | 2022 | 137 | 0.040 |
Why?
|
| Nepal | 1 | 2020 | 19 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 185 | 0.040 |
Why?
|
| AIDS Serodiagnosis | 1 | 2020 | 25 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2022 | 258 | 0.040 |
Why?
|
| Financing, Government | 1 | 2020 | 20 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 317 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 129 | 0.040 |
Why?
|
| Psychometrics | 1 | 2021 | 358 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 359 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 252 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 861 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1081 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 352 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 277 | 0.030 |
Why?
|
| Alabama | 1 | 2017 | 52 | 0.030 |
Why?
|
| Louisiana | 1 | 2017 | 50 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 518 | 0.030 |
Why?
|
| Mandatory Programs | 1 | 2016 | 5 | 0.030 |
Why?
|
| Virginia | 1 | 2016 | 12 | 0.030 |
Why?
|
| South Carolina | 1 | 2016 | 25 | 0.030 |
Why?
|
| Crime | 1 | 2016 | 29 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 587 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1154 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 440 | 0.030 |
Why?
|
| Spouse Abuse | 1 | 2016 | 52 | 0.030 |
Why?
|
| Tennessee | 1 | 2016 | 93 | 0.030 |
Why?
|
| Physician's Role | 1 | 2016 | 40 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 287 | 0.030 |
Why?
|
| Condoms | 1 | 2016 | 150 | 0.030 |
Why?
|
| Smoking | 1 | 2022 | 1024 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 667 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 118 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 127 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2014 | 64 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 706 | 0.030 |
Why?
|
| Marital Status | 1 | 2014 | 46 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2015 | 180 | 0.030 |
Why?
|
| School Health Services | 1 | 2014 | 90 | 0.020 |
Why?
|
| Health Status | 1 | 2016 | 442 | 0.020 |
Why?
|
| Mental Health | 1 | 2016 | 385 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1285 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1604 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 925 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1600 | 0.020 |
Why?
|